Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-20
2008-11-11
Witherspoon, Sikarl A (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S255060
Reexamination Certificate
active
07449469
ABSTRACT:
Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
REFERENCES:
patent: 3922293 (1975-11-01), Morozowich
patent: 4952581 (1990-08-01), Bito et al.
patent: 5625083 (1997-04-01), Bezuglov et al.
patent: 5811443 (1998-09-01), DeSantis, Jr. et al.
patent: 6211233 (2001-04-01), Del Soldato
patent: 6242432 (2001-06-01), Del Soldato
patent: 6417228 (2002-07-01), Klimko
patent: WO 90/02553 (1990-03-01), None
patent: WO 00/51978 (2000-09-01), None
patent: WO2005/068421 (2005-07-01), None
Arnuad, C.H., “Drug Hybrids Enter the Fray”,Chemical&Engineering News, 2007, 46-48, vol. 85, No. 46.
Beers, M.H., et al., The Merck Manual of Diagnosis and Therapy, Section 8, Chapter 100.
Greene, T.W., “Protective Groups in Organic Synthesis”, Harvard University Press, 1980, 14-118.
Greene, T.W., “Protective Groups in Organic Synthesis”, Harvard University Press, 1980, 68-86.
Benedini Francesca
Chiroli Valerio
Del Soldato Piero
Ongini Ennio
Hutchinson Keith D.
Nicox S.A.
Witherspoon Sikarl A
Zielinski Bryan C.
LandOfFree
Prostaglandin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4028733